Our finding that non-insulin-treated diabetes is associated with the highest odds of dilated cardiomyopathy aligns with these mechanistic insights, suggesting that early metabolic changes—even before escalation to insulin therapy—may predispose to structural remodelling. The gene discussed is INS; the disease is dilated cardiomyopathy.